SOPHiA GENETICS S.A. (SOPH)
SOPHiA GENETICS S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
SOPHiA GENETICS S.A. (SOPH) is a Medical - Healthcare Information Services company based in CH with a market capitalization of $360M. Revenue grew 18.6% year-over-year and free cash flow was negative at -$38.6M. This page tracks SOPH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CH · 423 employees · IPO Jul 23, 2021
Valuation
Valuation & price
$4.63as of May 17, 2026· -19.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
7.64
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$360M
Market cap
18.6%
Revenue growth (YoY)
61.9%
Gross margin
-$38.6M
Free cash flow (USD)
-$7.3M
Net debt
Net cash position
2.7%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
1
Insider buys · 90 days
53
Insider sells · 90 days
Earnings
Last report: 6-K filed Jun 22, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJun 29, 2026Filing
Insider Sell $298K · 10b5-1 PlanCamblong Jurgi · Director, Chief Executive Officer · $298.2K
- Insider sellJun 26, 2026Filing
Insider Sell $28K · 10b5-1 PlanMenu Philippe · Chief Medical Officer · $27.5K
- Insider sellJun 26, 2026Filing
Insider Sell $38K · 10b5-1 PlanVerma Abhimanyu · Chief Technology Officer · $38.2K
- Insider sellJun 23, 2026Filing
Insider Sell $2K · 10b5-1 PlanMuken Ross · President · $2.3K
- Insider sellJun 23, 2026Filing
Insider Sell $4K · 10b5-1 PlanCARDOZA GEORGE · Chief Financial Officer · $4.2K
- 6-K filingJun 22, 2026Filing
Underwriting Agreement
- Annual reportJun 22, 2026Filing
Annual Report Filed
- Insider sellJun 17, 2026Filing
Insider Sell $20K · 10b5-1 PlanXu Zhenyu · Chief Scientific Officer · $20.1K
- Insider sellJun 15, 2026Filing
Insider Sell $25K · 10b5-1 PlanMenu Philippe · Chief Medical Officer · $24.8K
- Insider sellJun 11, 2026Filing
Insider Sell $45K · 10b5-1 PlanCamblong Jurgi · Director, Chief Executive Officer · $44.5K
Questions
Frequently asked questions
What is SOPHiA GENETICS S.A.'s market cap?
SOPHiA GENETICS S.A. (SOPH) has a market capitalization of $360M.
What is SOPH's P/E ratio?
A meaningful P/E ratio is not available for SOPH — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SOPH's price-to-book (P/B) ratio?
SOPH trades at 7.64 times book value per share.
Are insiders buying SOPH stock?
Yes — SEC Form 4 filings show 1 open-market insider buy and 53 sells at SOPHiA GENETICS S.A. in the last 90 days.
Same arena
Related companies in Medical - Healthcare Information Services
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.